082850 — Wooree Bio Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩184bn
- KR₩178bn
- KR₩1tn
- 93
- 93
- 52
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 36,633 | 90,414 | 114,953 | 126,428 | 122,552 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 240,461 | 277,720 | 238,177 | 167,709 | 220,165 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 377,370 | 476,331 | 498,981 | 412,973 | 452,664 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 210,330 | 152,317 | 141,675 | 124,923 | 114,197 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 609,992 | 646,102 | 664,331 | 558,937 | 585,540 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 437,678 | 464,744 | 425,439 | 304,307 | 317,144 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 516,635 | 534,953 | 509,390 | 379,922 | 386,074 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 93,357 | 111,149 | 154,941 | 179,015 | 199,467 |
Total Liabilities & Shareholders' Equity | 609,992 | 646,102 | 664,331 | 558,937 | 585,540 |
Total Common Shares Outstanding |